Literature DB >> 25527026

Gastrointestinal acute radiation syndrome in Göttingen minipigs (Sus scrofa domestica).

Thomas B Elliott1, Nicolaas E Deutz2, Jatinder Gulani3, Amory Koch3, Cara H Olsen4, Christine Christensen5, Mark Chappell3, Mark H Whitnall4, Maria Moroni6.   

Abstract

In the absence of supportive care, exposing Göttingen minipigs to γ-radiation doses of less than 2 Gy achieves lethality due to hematopoietic acute radiation syndrome. Doses of 2 to 5 Gy are associated with an accelerated hematopoietic syndrome, characterized by villus blunting and fusion, the beginning of sepsis, and a mild transient reduction in plasma citrulline concentration. We exposed male Göttingen minipigs (age, 5 mo; weight, 9 to 11 kg) to γ-radiation doses of 5 to 12 Gy (total body; (60)Co, 0.6 Gy/min) to test whether these animals exhibit classic gastrointestinal acute radiation syndrome (GI-ARS). After exposure, the minipigs were monitored for 10 d by using clinical signs, CBC counts, and parameters associated with the development of the gastrointestinal syndrome. Göttingen minipigs exposed to γ radiation of 5 to 12 Gy demonstrate a dose-dependent occurrence of all parameters classically associated with acute GI-ARS. These results suggest that Göttingen minipigs may be a suitable model for studying GI-ARS after total body irradiation, but the use of supportive care to extend survival beyond 10 d is recommended. This study is the first step toward determining the feasibility of using Göttingen minipigs in testing the efficacy of candidate drugs for the treatment of GI-ARS after total body irradiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527026      PMCID: PMC4275081     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  20 in total

1.  Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

Authors:  Ludy C H W Lutgens; Nicole M A Blijlevens; Nicolaas E P Deutz; J Peter Donnelly; Philippe Lambin; Ben E de Pauw
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

Review 2.  A comprehensive study of the radiobiological response of the murine (BDF1) small intestine.

Authors:  C S Potten
Journal:  Int J Radiat Biol       Date:  1990-12       Impact factor: 2.694

3.  Development of a new minipig model to study radiation-induced gastrointestinal syndrome and its application in clinical research.

Authors:  Sehwan Shim; Won-Suk Jang; Sun-Joo Lee; Sungho Jin; Jin Kim; Seung-Sook Lee; Ho Yoon Bang; Byung Suk Jeon; Sunhoo Park
Journal:  Radiat Res       Date:  2014-04       Impact factor: 2.841

4.  Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.

Authors:  P Crenn; C Coudray-Lucas; F Thuillier; L Cynober; B Messing
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

5.  Hematopoietic radiation syndrome in the Gottingen minipig.

Authors:  Maria Moroni; Thea V Coolbaugh; Eric Lombardini; Jennifer M Mitchell; Krinon D Moccia; Larry J Shelton; Vitaly Nagy; Mark H Whitnall
Journal:  Radiat Res       Date:  2011-04-26       Impact factor: 2.841

6.  Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.

Authors:  Jamie K Waselenko; Thomas J MacVittie; William F Blakely; Nicki Pesik; Albert L Wiley; William E Dickerson; Horace Tsu; Dennis L Confer; C Norman Coleman; Thomas Seed; Patrick Lowry; James O Armitage; Nicholas Dainiak
Journal:  Ann Intern Med       Date:  2004-06-15       Impact factor: 25.391

7.  Bile loss in the acute intestinal radiation syndrome in rats.

Authors:  J P Geraci; S G Dunston; K L Jackson; M S Mariano; C Holeski; D L Eaton
Journal:  Radiat Res       Date:  1987-01       Impact factor: 2.841

8.  Morphological changes of rat jejunum after whole body gamma-irradiation and their impact in biodosimetry.

Authors:  D Driák; J Osterreicher; J Vávrová; Z Řeháková; Z Vilasová
Journal:  Physiol Res       Date:  2007-04-25       Impact factor: 1.881

9.  Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.

Authors:  Michel J van Vliet; Wim J E Tissing; Edmond H H M Rings; Harma A Koetse; Frans Stellaard; Willem A Kamps; Eveline S J M de Bont
Journal:  Pediatr Blood Cancer       Date:  2009-12-15       Impact factor: 3.167

10.  Effect of irradiation on morphology and motility of canine small intestine.

Authors:  R W Summers; A J Flatt; M J Prihoda; F A Mitros
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

View more
  12 in total

1.  Citrulline as a Biomarker in the Murine Total-Body Irradiation Model: Correlation of Circulating and Tissue Citrulline to Small Intestine Epithelial Histopathology.

Authors:  Jace W Jones; Gregory Tudor; Fei Li; Yan Tong; Barry Katz; Ann M Farese; Thomas J MacVittie; Catherine Booth; Maureen A Kane
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

2.  Surface-enhanced Raman spectroscopy competitive binding biosensor development utilizing surface modification of silver nanocubes and a citrulline aptamer.

Authors:  Brian M Walton; George W Jackson; Nicolaas Deutz; Gerard Cote
Journal:  J Biomed Opt       Date:  2017-07-01       Impact factor: 3.170

3.  Selective Insulin-like Growth Factor Resistance Associated with Heart Hemorrhages and Poor Prognosis in a Novel Preclinical Model of the Hematopoietic Acute Radiation Syndrome.

Authors:  Doreswamy Kenchegowda; Betre Legesse; Bernadette Hritzo; Cara Olsen; Saeed Aghdam; Amandeep Kaur; William Culp; Alexandrine Derrien-Colemyn; Grant Severson; Maria Moroni
Journal:  Radiat Res       Date:  2018-05-29       Impact factor: 2.841

4.  Promising role of filgrastim and α-tocopherol succinate in amelioration of gastrointestinal acute radiation syndrome (GI-ARS) in mice.

Authors:  Heba A Gheita; Walaa A El-Sabbagh; Rania M Abdelsalam; Amina S Attia; Mona A El-Ghazaly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-27       Impact factor: 3.000

5.  Citrulline as a Biomarker in the Non-human Primate Total- and Partial-body Irradiation Models: Correlation of Circulating Citrulline to Acute and Prolonged Gastrointestinal Injury.

Authors:  Jace W Jones; Alexander Bennett; Claire L Carter; Gregory Tudor; Kim G Hankey; Ann M Farese; Catherine Booth; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

6.  The effects of N-acetylcysteine on radiotherapy-induced small intestinal damage in rats.

Authors:  Filiz Mercantepe; Atilla Topcu; Sema Rakici; Levent Tumkaya; Adnan Yilmaz
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-20

7.  Methionine dietary supplementation potentiates ionizing radiation-induced gastrointestinal syndrome.

Authors:  Isabelle R Miousse; Laura E Ewing; Charles M Skinner; Rupak Pathak; Sarita Garg; Kristy R Kutanzi; Stepan Melnyk; Martin Hauer-Jensen; Igor Koturbash
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

Review 8.  Acute Radiation Syndrome and the Microbiome: Impact and Review.

Authors:  Brynn A Hollingsworth; David R Cassatt; Andrea L DiCarlo; Carmen I Rios; Merriline M Satyamitra; Thomas A Winters; Lanyn P Taliaferro
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

9.  Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.

Authors:  Thomas B Elliott; David L Bolduc; G David Ledney; Juliann G Kiang; Oluseyi O Fatanmi; Stephen Y Wise; Patricia L P Romaine; Victoria L Newman; Vijay K Singh
Journal:  Int J Radiat Biol       Date:  2015-06-08       Impact factor: 2.694

10.  Dysregulated Cardiac IGF-1 Signaling and Antioxidant Response Are Associated with Radiation Sensitivity.

Authors:  Saeed Y Aghdam; Doreswamy Kenchegowda; Neel K Sharma; Gregory P Holmes-Hampton; Betre Legesse; Maria Moroni; Sanchita P Ghosh
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.